Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
41.49
+1.95 (4.93%)
Dec 20, 2024, 4:00 PM EST - Market closed
Protagonist Therapeutics Employees
Protagonist Therapeutics had 112 employees as of December 31, 2023. The number of employees increased by 7 or 6.67% compared to the previous year.
Employees
112
Change (1Y)
7
Growth (1Y)
6.67%
Revenue / Employee
$2,891,027
Profits / Employee
$1,525,438
Market Cap
2.47B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Select Medical Holdings | 54,600 |
Addus HomeCare | 34,846 |
Ardent Health Partners | 23,000 |
Amneal Pharmaceuticals | 7,700 |
Azenta | 3,300 |
Privia Health Group | 1,102 |
Arrowhead Pharmaceuticals | 609 |
Dyne Therapeutics | 141 |
PTGX News
- 2 days ago - Protagonist Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference 2025 - Accesswire
- 4 weeks ago - Protagonist Therapeutics to Participate in the 7th Annual Evercore ISI HealthCONx Conference 2024 - Accesswire
- 4 weeks ago - Protagonist Therapeutics to Host Conference Call to Announce an Oral Peptide IL-17 Antagonist Development Candidate - Accesswire
- 6 weeks ago - Protagonist Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Accesswire
- 6 weeks ago - Protagonist Therapeutics Announces Poster Presentation on Final REVIVE Phase 2 Study Data with Rusfertide at the 66th Annual ASH Meeting - Accesswire
- 3 months ago - Protagonist Therapeutics' Two Investigational Candidates Target Over $10B Market, Bullish Analyst Opines - Benzinga
- 3 months ago - Protagonist Therapeutics to Participate in the H.C. Wainwright 26th Annual Global Investment Conference 2024 - Accesswire
- 4 months ago - Protagonist Reports Second Quarter 2024 Financial Results and Provides Corporate Update - Accesswire